(Daily Mail) A top vaccine expert and pediatric doctor is cautioning parents of healthy young people to hold off getting the new COVID booster shot, saying it can carry risks and its efficacy hasn’t yet been proven.
Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia and a member of the Food and Drug Administration’s Vaccine Advisory Committee, said he’s not fully sold on the benefits of a third shot outweighing the harm.
‘Who really benefits from another dose?’ Offit said on CNN.
He did acknowledge that studies have shown people who are over 65, immuno-compromised or have a chronic ailments are less likely to be hospitalized with the virus if they’ve had a third or even fourth shot.
The newly developed dose, called a bivalent vaccine, is a cocktail of the original coronavirus strain combined with parts of the omicron BA.4 and BA.5 subvariants. The hope being that people would be able to fight a broader range of more highly contagious virus mutations.
But writing in the Wall Street Journal earlier this week, Offitt said preliminary data suggested the new bivalent vaccines were actually worse at warding off COVID infections than the first generation of shots.
He highlighted data comparing Moderna’s original COVID vaccine and its new bivalent update. Of a test group given both shots, 11 people who’d received bivalent vaccines contracted the virus, while just five people who received the original ‘monovalent’ shot caught COVID.
Offit warned that the Biden administration that ‘overselling’ the new bivalent vaccines without more data could ‘erode the public’s trust’ in them.
FDA advisor and vaccine maker Paul Offit: “A healthy young person is unlikely to benefit from a booster dose… If there’s not clear evidence of benefit, then it’s not fair to ask people to take a risk.” pic.twitter.com/SgBp5WZbMS
— Max Blumenthal (@MaxBlumenthal) September 24, 2022
Dr. Paul Offit, right, cautions that there are still risks for healthy young people that should be considered before getting the COVID booster shot
Sean Bagley, 14, seen here, recently got the bivalent vaccine in Skippack Pharmacy in Schwenksville, Penn.
He explained that the FDA’s recent approval of a the new vaccine cooked up by Moderna and Pfizer-BioNTech comes with little assurances and some risks.
‘A healthy young person is unlikely to benefit from the extra dose,’ he said.
The Centers for Disease Control and Prevention have reported that vaccine side-effects, like myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the heart’s outer lining, are rare, but they most often occur in adolescents and young men.
Myocarditis can even be fatal, with young people far less likely to suffer a severe COVID infection than older people.
